The role of colposcopy and HPV-DNA test in the diagnosis of HSIL patients

BI Hui,ZHAO Jian,CHEN Rui
DOI: https://doi.org/10.3969/j.issn.1672-1861.2011.04.006
2011-01-01
Abstract:Objective To understand the role of single-time colposcopy and HPV-DNA genotyping test in the diagnosis of HSIL patients.Methods 551 patients whose cervical cytology test results were HSIL underwent immediate colposcopy detection from January 2005 to December 2007,multiple punch biopsy was taken for 519 patients who had abnormal findings under colposcopy,for those unsatisfied colposcopy test,cervical curettage were added.Results Among the 551 cases of HSIL patients,there were 58(10.5%) cases of CIN 1,334(62.4%) cases of CIN 2 and CIN 3,11(2%) cases of cervical cancer diagnosed by multi-point biopsy under single-time colpscopy.The occurrence in different age groups had significant difference(P=0.034).Meanwhile 376 HSIL patients received HPV-DNA genotyping test,the positive rate of high-risk HPV was 87.5%,and the most common subtype was HPV 16(45.7%).In HR-HPV positive group,especially HPV 16 subtype positive group,the detection rate of CIN2 was significant higher than that in the HR-HPV negative group(P=0.000).Conclusions Only 62.4% patients of CIN2 and more advanced lesion were diagnosed under single-time colposcopy.HPV-DNA genotyping test may help increasing the detection rate of CIN and cervical cancer.We should pay more attention to HSIL patients whose colposcopy test has no abnormal findings.
What problem does this paper attempt to address?